Sitagliptin phosphate monohydrate
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 1mL(10 mM in DMSO) | ¥500.00 | 现货 | |
| 200mg | ¥545.00 | 现货 | |
| 500mg | ¥1000.00 | 现货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
Sitagliptin phosphate monohydrate是其活性成分西他列汀(sitagliptin)的磷酸盐加上一分子的水。Sitagliptin是二肽基肽酶(DPP-4)的有效抑制剂,选择性抑制DPP-4,IC50值为18 nM,而对其它的DDP酶(如DDP-8和DDP-9)没有亲和性。DPP-4是一种酶,催化N端为丙氨酸或脯氨酸残基的多肽水解。据报道,sitagliptin通过增加两种DPP-4底物的水平,包括胰高血糖素样肽-1(GLP-1)和肠抑胃肽(GIP),从而抑制DPP4。Sitagliptin目前正用于治疗II型糖尿病的研究。
参考文献:
Gallwitz B. Review of sitagliptin phosphate: a novel treatment for type 2 diabetes. Vasc Health Risk Manag. 2007;3(2):203-10.
产品性质
| 物理外观 | A solid |
| CAS号 | 654671-77-9 |
| 分子式 | C16H15F6N5O·H3PO4·H2O |
| 分子量 | 523.3 |
| 化学名称 | (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate |
| 溶解度 | ≥23.8 mg/mL in DMSO; insoluble in EtOH; ≥30.6 mg/mL in H2O with ultrasonic |
| SMILES | [HH].C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OOP(=O)=O |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | Sitagliptin phosphate是一种有效的DPP-IV抑制剂,在Caco-2细胞提取物中的IC50值为19 nM。 |
| 靶点 | DPP-4 |
| 生物活性数据 | 19 nM |
生物相关数据
质量控制
APExBIO 顾客使用本产品发表的 10 篇科研文献
3. McCloskey AG, Miskelly MG, et al. "Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice." Biochem Pharmacol 2023 Feb;208. PMID: 36581052
4. Craig SL, Gault VA, et al. "Ψ-xenin-6 enhances sitagliptin effectiveness, but does not improve glucose tolerance." J Endocrinol. 2020;245(2):219-230. PMID: 32130206
5. McCloskey AG, Miskelly MG, et al. "Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis." Eur J Pharm Sci. 2020;142:105104. PMID: 31669388
6. Mansur SA, Mieczkowska A, et al. "Sitagliptin Alters Bone Composition in High-Fat-Fed Mice." Calcif Tissue Int. 2018 Dec 18. PMID: 30564859
7. Ghorpade DS, Ozcan L, et al. "Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance." Nature. 2018 Mar 29;555(7698):673-677. PMID: 29562231
8. Mroz PA, Perez-Tilve D, et al. "Native Design of Soluble, Aggregation-Resistant Bioactive Peptides: Chemical Evolution of Human Glucagon." ACS Chem Biol. 2016 Dec 16;11(12):3412-3420. PMID: 27797473
9. Khan D, Vasu S, et al. "Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival." Mol Cell Endocrinol. 2016 Jul 25;436:102-113. PMID: 27465830
10. Gault, V. A., R. Lennox, and P. R. Flatt. "Sitagliptin, a DPP‐4 inhibitor, improves recognition memory, oxidative stress, hippocampal neurogenesis and up‐regulates key genes involved in cognitive decline." Diabetes, Obesity and Metabolism (2015) PMID: 25580570



沪公网安备 31011002003500